# Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease

> **NCT03056729** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 46 (actual)

## Conditions studied

- Alzheimer's Disease
- Healthy Volunteer

## Interventions

- **DRUG:** BIIB076
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03056729
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-17
- **Primary completion:** 2020-03-03
- **Final completion:** 2020-03-03
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03056729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03056729, "Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03056729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*